Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
RXRX.OQ - Recursion Pharmaceuticals Inc
Q2 2025 Recursion Pharmaceuticals Inc Earnings Call
Aug 05, 2025 / 12:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome everybody to Recursion's Q2 2025 earnings call. My name is Chris Gibson and I'm the co-founder and CEO of Recursion. And I'm excited to share with you today some of the latest updates on our company as we drive forward to decode biology.
We've been talking for the last 9 months since the business combination with Accentia about the recursion OS 2.0, and I want to start there today and tell you a little bit about the way that we're bringing together the incredible components from both Accentsia and recursion and building new components of the OS in order to drive forward our mission. At recursion, we base everything off of proprietary fit for purpose data, whether it's data we generate in
Trustpilot
